Wyoming activists are kicking it into high gear to collect signatures for 2022 ballot initiatives to legalize medical marijuana and decriminalize cannabis possession, with the campaign announcing a series of events this weekend to shore up support.

Wesana Health closes on its acquisition of PsyTech, solidifying its business model as it seeks a U.S. listing.

Roughly 8 million people per year are dying preventable deaths because of lack of (legal) access to psychedelic medicine. It’s also killing the economy.

Mydecine and Johns Hopkins plan a “seamless” (combined) Phase II/III clinical trial of MYCO-001 to treat nicotine addiction.

The California Department of Fish and Wildlife last week called for concept proposals from cannabis cultivators for its upcoming Cannabis Restoration Grant Program.

Red Light Holland closes on its majority ownership in Acadian Exotic Mushrooms, now holding a 51% interest.

The Washington State attorney general’s office appeared alongside lawyers representing cancer patients on Thursday, telling a federal appeals panel that people in end-of-life care deserve legal access to psilocybin under state and federal right-to-try laws.

New York lawmakers approved two officials for the state’s adult-use cannabis program in a special session this week, WHAM reports.

MINDCURE reports a net loss for the fiscal year of CAD$10.2 million as it prepares to deploy its iSTRYM digital therapeutics platform. Cash and equivalents of CAD$18.3 million.

The DEA fights to keep psychedelic drugs illegal while it admits these drugs have valuable medical uses. Meanwhile, Americans are dying every day from lack of legal access.